Skip to main content
OpenTrials

Clinical trial condition

Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)

Explore clinical trials studying Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL) trial results

Completed

Acalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma

NCT02112526

Conditions
Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site New York, United States
  • Research Site Columbus, Ohio, United States
View Trial Details

Related conditions